BOOKING HOLDINGS INC (PCE1.DE) Fundamental Analysis & Valuation

FRA:PCE1 • US09857L1089

Current stock price

3589 EUR
-21 (-0.58%)
Last:

This PCE1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PCE1.DE Profitability Analysis

1.1 Basic Checks

  • In the past year PCE1 was profitable.
  • PCE1 had a positive operating cash flow in the past year.
  • PCE1 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years PCE1 had a positive operating cash flow.
PCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFPCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

1.2 Ratios

  • PCE1 has a better Return On Assets (18.47%) than 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 60.31%, PCE1 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PCE1 is significantly above the industry average of 11.34%.
  • The 3 year average ROIC (52.44%) for PCE1 is below the current ROIC(60.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.47%
ROE N/A
ROIC 60.31%
ROA(3y)19.1%
ROA(5y)14.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.44%
ROIC(5y)38.4%
PCE1.DE Yearly ROA, ROE, ROICPCE1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 -150

1.3 Margins

  • The Profit Margin of PCE1 (20.08%) is better than 89.29% of its industry peers.
  • In the last couple of years the Profit Margin of PCE1 has grown nicely.
  • PCE1 has a better Operating Margin (35.25%) than 96.43% of its industry peers.
  • PCE1's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 35.25%
PM (TTM) 20.08%
GM N/A
OM growth 3Y8.35%
OM growth 5Y40.5%
PM growth 3Y3.91%
PM growth 5Y87.42%
GM growth 3YN/A
GM growth 5YN/A
PCE1.DE Yearly Profit, Operating, Gross MarginsPCE1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PCE1.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PCE1 is creating value.
  • PCE1 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PCE1 has less shares outstanding
  • Compared to 1 year ago, PCE1 has a worse debt to assets ratio.
PCE1.DE Yearly Shares OutstandingPCE1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
PCE1.DE Yearly Total Debt VS Total AssetsPCE1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • PCE1 has an Altman-Z score of 6.42. This indicates that PCE1 is financially healthy and has little risk of bankruptcy at the moment.
  • PCE1 has a Altman-Z score of 6.42. This is amongst the best in the industry. PCE1 outperforms 96.43% of its industry peers.
  • PCE1 has a debt to FCF ratio of 2.06. This is a good value and a sign of high solvency as PCE1 would need 2.06 years to pay back of all of its debts.
  • PCE1's Debt to FCF ratio of 2.06 is fine compared to the rest of the industry. PCE1 outperforms 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.06
Altman-Z 6.42
ROIC/WACC7.14
WACC8.45%
PCE1.DE Yearly LT Debt VS Equity VS FCFPCE1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

2.3 Liquidity

  • PCE1 has a Current Ratio of 1.33. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
  • PCE1 has a Current ratio of 1.33. This is amongst the best in the industry. PCE1 outperforms 85.71% of its industry peers.
  • PCE1 has a Quick Ratio of 1.33. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
  • PCE1's Quick ratio of 1.33 is amongst the best of the industry. PCE1 outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
PCE1.DE Yearly Current Assets VS Current LiabilitesPCE1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PCE1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.72% over the past year.
  • PCE1 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 117.82% yearly.
  • Looking at the last year, PCE1 shows a quite strong growth in Revenue. The Revenue has grown by 13.39% in the last year.
  • The Revenue has been growing by 31.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)21.72%
EPS 3Y31.39%
EPS 5Y117.82%
EPS Q2Q%17.45%
Revenue 1Y (TTM)13.39%
Revenue growth 3Y16.35%
Revenue growth 5Y31.69%
Sales Q2Q%16.05%

3.2 Future

  • PCE1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.94% yearly.
  • Based on estimates for the next years, PCE1 will show a quite strong growth in Revenue. The Revenue will grow by 8.68% on average per year.
EPS Next Y19.2%
EPS Next 2Y17.97%
EPS Next 3Y17.61%
EPS Next 5Y16.94%
Revenue Next Year12.23%
Revenue Next 2Y10.38%
Revenue Next 3Y9.66%
Revenue Next 5Y8.68%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PCE1.DE Yearly Revenue VS EstimatesPCE1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
PCE1.DE Yearly EPS VS EstimatesPCE1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200 400 600

More info and screens

Find the best growth stocksShow best growing peers

6

4. PCE1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.04, PCE1 is valued on the expensive side.
  • Based on the Price/Earnings ratio, PCE1 is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • PCE1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.35.
  • With a Price/Forward Earnings ratio of 15.13, PCE1 is valued correctly.
  • PCE1's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PCE1 is cheaper than 75.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.61, PCE1 is valued a bit cheaper.
Industry RankSector Rank
PE 18.04
Fwd PE 15.13
PCE1.DE Price Earnings VS Forward Price EarningsPCE1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as PCE1.
  • 62.50% of the companies in the same industry are more expensive than PCE1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.36
EV/EBITDA 13.14
PCE1.DE Per share dataPCE1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200 400 600

4.3 Compensation for Growth

  • PCE1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PCE1 has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PCE1's earnings are expected to grow with 17.61% in the coming years.
PEG (NY)0.94
PEG (5Y)0.15
EPS Next 2Y17.97%
EPS Next 3Y17.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. PCE1.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.93%, PCE1 is not a good candidate for dividend investing.
  • The stock price of PCE1 dropped by -20.01% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • PCE1's Dividend Yield is a higher than the industry average which is at 1.31.
  • With a Dividend Yield of 0.93, PCE1 pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.93%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PCE1.DE Yearly Dividends per sharePCE1.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 10 20 30

5.3 Sustainability

  • PCE1 pays out 23.09% of its income as dividend. This is a sustainable payout ratio.
DP23.09%
EPS Next 2Y17.97%
EPS Next 3Y17.61%
PCE1.DE Yearly Income VS Free CF VS DividendPCE1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B
PCE1.DE Dividend Payout.PCE1.DE Dividend Payout, showing the Payout Ratio.PCE1.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PCE1.DE Fundamentals: All Metrics, Ratios and Statistics

BOOKING HOLDINGS INC

FRA:PCE1 (3/31/2026, 7:00:00 PM)

3589

-21 (-0.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-18
Earnings (Next)04-27
Inst Owners111.97%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap113.66B
Revenue(TTM)26.92B
Net Income(TTM)5.40B
Analysts81.33
Price Target4957.26 (38.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.93%
Yearly Dividend33.42
Dividend Growth(5Y)N/A
DP23.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.35%
Min EPS beat(2)-1.28%
Max EPS beat(2)1.98%
EPS beat(4)3
Avg EPS beat(4)12.3%
Min EPS beat(4)-1.28%
Max EPS beat(4)40.35%
EPS beat(8)7
Avg EPS beat(8)14.67%
EPS beat(12)11
Avg EPS beat(12)13.5%
EPS beat(16)15
Avg EPS beat(16)31.78%
Revenue beat(2)2
Avg Revenue beat(2)1.42%
Min Revenue beat(2)1.28%
Max Revenue beat(2)1.55%
Revenue beat(4)4
Avg Revenue beat(4)1.56%
Min Revenue beat(4)1.28%
Max Revenue beat(4)1.73%
Revenue beat(8)7
Avg Revenue beat(8)1.73%
Revenue beat(12)8
Avg Revenue beat(12)1.2%
Revenue beat(16)11
Avg Revenue beat(16)1.12%
PT rev (1m)0%
PT rev (3m)-7.91%
EPS NQ rev (1m)-0.98%
EPS NQ rev (3m)-8.71%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)3.41%
Revenue NY rev (1m)2.65%
Revenue NY rev (3m)3.02%
Valuation
Industry RankSector Rank
PE 18.04
Fwd PE 15.13
P/S 4.85
P/FCF 14.36
P/OCF 13.87
P/B N/A
P/tB N/A
EV/EBITDA 13.14
EPS(TTM)198.98
EY5.54%
EPS(NY)237.19
Fwd EY6.61%
FCF(TTM)249.85
FCFY6.96%
OCF(TTM)258.7
OCFY7.21%
SpS740.09
BVpS-153.37
TBVpS-251.99
PEG (NY)0.94
PEG (5Y)0.15
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 18.47%
ROE N/A
ROCE 75.5%
ROIC 60.31%
ROICexc N/A
ROICexgc N/A
OM 35.25%
PM (TTM) 20.08%
GM N/A
FCFM 33.76%
ROA(3y)19.1%
ROA(5y)14.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.44%
ROIC(5y)38.4%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)65.64%
ROCE(5y)48.08%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y8.35%
OM growth 5Y40.5%
PM growth 3Y3.91%
PM growth 5Y87.42%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.06
Debt/EBITDA 1.67
Cap/Depr 51.69%
Cap/Sales 1.2%
Interest Coverage 8.62
Cash Conversion 93.07%
Profit Quality 168.15%
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 6.42
F-Score6
WACC8.45%
ROIC/WACC7.14
Cap/Depr(3y)64.24%
Cap/Depr(5y)69.31%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.91%
Profit Quality(3y)155.18%
Profit Quality(5y)176.76%
High Growth Momentum
Growth
EPS 1Y (TTM)21.72%
EPS 3Y31.39%
EPS 5Y117.82%
EPS Q2Q%17.45%
EPS Next Y19.2%
EPS Next 2Y17.97%
EPS Next 3Y17.61%
EPS Next 5Y16.94%
Revenue 1Y (TTM)13.39%
Revenue growth 3Y16.35%
Revenue growth 5Y31.69%
Sales Q2Q%16.05%
Revenue Next Year12.23%
Revenue Next 2Y10.38%
Revenue Next 3Y9.66%
Revenue Next 5Y8.68%
EBIT growth 1Y25.01%
EBIT growth 3Y26.07%
EBIT growth 5Y85.03%
EBIT Next Year25.76%
EBIT Next 3Y15.72%
EBIT Next 5Y13.24%
FCF growth 1Y15.11%
FCF growth 3Y13.68%
FCF growth 5YN/A
OCF growth 1Y13.05%
OCF growth 3Y12.81%
OCF growth 5Y156.35%

BOOKING HOLDINGS INC / PCE1.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BOOKING HOLDINGS INC?

ChartMill assigns a fundamental rating of 7 / 10 to PCE1.DE.


What is the valuation status for PCE1 stock?

ChartMill assigns a valuation rating of 6 / 10 to BOOKING HOLDINGS INC (PCE1.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for BOOKING HOLDINGS INC?

BOOKING HOLDINGS INC (PCE1.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of BOOKING HOLDINGS INC (PCE1.DE) stock?

The Price/Earnings (PE) ratio for BOOKING HOLDINGS INC (PCE1.DE) is 18.04 and the Price/Book (PB) ratio is -23.4.


How financially healthy is BOOKING HOLDINGS INC?

The financial health rating of BOOKING HOLDINGS INC (PCE1.DE) is 7 / 10.